Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5676138 | American Journal of Obstetrics and Gynecology | 2016 | 33 Pages |
Abstract
Several clinical characteristics define women at risk for recurrent preterm birth at a similar gestational age despite 17-alpha hydroxyprogesterone caproate therapy and can be used to generate a clinical risk predictor score. These data should be refined and confirmed in other cohorts, and women at high risk for nonresponse should be targets for novel therapeutic intervention studies.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Tracy A. MD, Gregory J. MS, Rebecca C. PhD, M. Sean MD, Michael W. MD,